Hepatitis C: efficacy and safety in real life.

Hepatitis C: efficacy and safety in real life.

Item
http://www.wikidata.org/entity/Q39040719
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study.Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.The potential of signal peptide peptidase as a therapeutic target for hepatitis C.Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study.Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments.Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.
P2860

Hepatitis C: efficacy and safety in real life.

Item
http://www.wikidata.org/entity/Q39040719
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Hepatitis C: efficacy and safety in real life.
@en
Hepatitis C: efficacy and safety in real life.
@nl
type
label
Hepatitis C: efficacy and safety in real life.
@en
Hepatitis C: efficacy and safety in real life.
@nl
prefLabel
Hepatitis C: efficacy and safety in real life.
@en
Hepatitis C: efficacy and safety in real life.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P356
P1433
P1476
Hepatitis C: efficacy and safety in real life
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P698